SUSQUEHANNA INTERNATIONAL GROUP, LLP
Position in ELVN — Enliven Therapeutics, Inc.
CIK 1446194
BALA CYNWYD, PA
Position in ELVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$202,644
-$784,098 QoQ
Shares Held
3,993
-84.1% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#171
of 210 holders
Holding Since
Mar 2023
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ELVN Over Time
Shares Held
Position Value (USD)
Derivatives in ELVN
reported options exposure · as of Jun 30, 2026CallValue
$4,892,300
CallShares
96,400
PutValue
$1,055,600
PutShares
20,800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,649,997,309 across 349 Biotechnology names. ELVN ranks #229 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
1,053,896 | $140,442,180 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,549,458 | $131,998,327 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
180,219 | $112,373,755 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
294,460 | $88,641,293 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
148,610 | $79,796,139 | |
| 6 | INSM |
INSMED Inc
|
729,354 | $77,763,723 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
144,174 | $71,615,550 | |
| 8 | AGIO |
Agios Pharmaceuticals, Inc.
|
1,375,558 | $51,046,957 |
All Filings in ELVN
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,892,300 | 96,400 | Call | Other | 2026-08-14 | |
| 2026-06-30 | $1,055,600 | 20,800 | Put | Other | 2026-08-14 | |
| 2026-06-30 | $202,644 | 3,993 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $2,669,520 | 68,100 | Call | Other | 2026-05-15 | |
| 2026-03-31 | $986,742 | 25,172 | Shares | Other | 2026-05-15 | |
| 2026-03-31 | $4,441,360 | 113,300 | Put | Other | 2026-05-15 | |
| 2025-09-30 | $1,207,730 | 59,000 | Put | Other | 2025-11-14 | |
| 2025-09-30 | $643,535 | 31,438 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $1,115,917 | 55,629 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $883,927 | 44,915 | Shares | Other | 2025-05-14 | |
| 2024-12-31 | $349,425 | 15,530 | Shares | Other | 2025-02-14 | |
| 2024-06-30 | $203,319 | 8,700 | Call | Defined | 2024-08-15 | |
| 2023-09-30 | $148,894 | 10,900 | Call | Defined | 2023-11-14 | |
| 2023-03-31 | $3,931,050 | 179,500 | Call | Defined | 2023-05-16 | |
| 2023-03-31 | $375,957 | 17,167 | Shares | Defined | 2023-05-16 | |
| No filing history on record for this holder in this stock. | ||||||